- Home
- BTE vs ITGR Comparison
BTE vs ITGR Comparison
Compare BTE & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTE | ITGR |
|---|---|---|
| Founded | 1993 | 1970 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Meat/Poultry/Fish | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.0B |
| IPO Year | 2004 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BTE | ITGR |
|---|---|---|
| Price | $4.23 | $89.49 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $91.14 |
| AVG Volume (30 Days) | ★ 24.1M | 376.7K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.89 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | N/A | $1.69 |
| Revenue Next Year | $7.93 | $6.53 |
| P/E Ratio | ★ $18.43 | $31.27 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $1.44 | $62.00 |
| 52 Week High | $4.56 | $127.56 |
Technical Indicators
Market Signals| Indicator | BTE | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 52.70 | 57.95 |
| Support Level | $3.95 | $82.58 |
| Resistance Level | $4.56 | $110.93 |
| Average True Range (ATR) | 0.19 | 2.05 |
| MACD | -0.03 | 0.33 |
| Stochastic Oscillator | 47.24 | 74.21 |
Price Performance
Historical ComparisonAbout BTE Baytex Energy Corp
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.